Unlike the previous work conducted by Duan et al. 27, they only investigated one polymorphism in EXO1 and cancer risk and concluded that rs1047840 polymorphism A allele may be applied as a novel biomarker for tumour susceptibility. The gene discussed is EXO1; the disease is neoplasm.